Global Hepatic Encephalopathy Drugs Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Hepatic Encephalopathy Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Hepatic Encephalopathy Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Hepatic Encephalopathy Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Hepatic Encephalopathy Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hepatic Encephalopathy Drugs market, reaching US$ million by the year 2028. As for the Europe Hepatic Encephalopathy Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Hepatic Encephalopathy Drugs players cover ASKA Pharmaceutical, Cosmo Pharmaceuticals, Bausch Health, and Ferring Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatic Encephalopathy Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Hepatic Encephalopathy Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Hepatic Encephalopathy Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Hepatic Encephalopathy Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Hepatic Encephalopathy Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hepatic Encephalopathy Drugs market, reaching US$ million by the year 2028. As for the Europe Hepatic Encephalopathy Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Hepatic Encephalopathy Drugs players cover ASKA Pharmaceutical, Cosmo Pharmaceuticals, Bausch Health, and Ferring Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatic Encephalopathy Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Injection
- Oral
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ASKA Pharmaceutical
- Cosmo Pharmaceuticals
- Bausch Health
- Ferring Pharmaceuticals
- Mallinckrodt
- Umecrine Cognition
- Norgine
- Lupin
- Kaleido Biosciences
- Kannalife Sciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hepatic Encephalopathy Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Hepatic Encephalopathy Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Hepatic Encephalopathy Drugs by Country/Region, 2017, 2022 & 2028
2.2 Hepatic Encephalopathy Drugs Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 Hepatic Encephalopathy Drugs Sales by Type
2.3.1 Global Hepatic Encephalopathy Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Hepatic Encephalopathy Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Hepatic Encephalopathy Drugs Sale Price by Type (2017-2022)
2.4 Hepatic Encephalopathy Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Hepatic Encephalopathy Drugs Sales by Application
2.5.1 Global Hepatic Encephalopathy Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Hepatic Encephalopathy Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Hepatic Encephalopathy Drugs Sale Price by Application (2017-2022)
3 GLOBAL HEPATIC ENCEPHALOPATHY DRUGS BY COMPANY
3.1 Global Hepatic Encephalopathy Drugs Breakdown Data by Company
3.1.1 Global Hepatic Encephalopathy Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Hepatic Encephalopathy Drugs Sales Market Share by Company (2020-2022)
3.2 Global Hepatic Encephalopathy Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Hepatic Encephalopathy Drugs Revenue by Company (2020-2022)
3.2.2 Global Hepatic Encephalopathy Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Hepatic Encephalopathy Drugs Sale Price by Company
3.4 Key Manufacturers Hepatic Encephalopathy Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatic Encephalopathy Drugs Product Location Distribution
3.4.2 Players Hepatic Encephalopathy Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HEPATIC ENCEPHALOPATHY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Hepatic Encephalopathy Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Hepatic Encephalopathy Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Hepatic Encephalopathy Drugs Annual Revenue by Geographic Region
4.2 World Historic Hepatic Encephalopathy Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Hepatic Encephalopathy Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Hepatic Encephalopathy Drugs Annual Revenue by Country/Region
4.3 Americas Hepatic Encephalopathy Drugs Sales Growth
4.4 APAC Hepatic Encephalopathy Drugs Sales Growth
4.5 Europe Hepatic Encephalopathy Drugs Sales Growth
4.6 Middle East & Africa Hepatic Encephalopathy Drugs Sales Growth
5 AMERICAS
5.1 Americas Hepatic Encephalopathy Drugs Sales by Country
5.1.1 Americas Hepatic Encephalopathy Drugs Sales by Country (2017-2022)
5.1.2 Americas Hepatic Encephalopathy Drugs Revenue by Country (2017-2022)
5.2 Americas Hepatic Encephalopathy Drugs Sales by Type
5.3 Americas Hepatic Encephalopathy Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatic Encephalopathy Drugs Sales by Region
6.1.1 APAC Hepatic Encephalopathy Drugs Sales by Region (2017-2022)
6.1.2 APAC Hepatic Encephalopathy Drugs Revenue by Region (2017-2022)
6.2 APAC Hepatic Encephalopathy Drugs Sales by Type
6.3 APAC Hepatic Encephalopathy Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hepatic Encephalopathy Drugs by Country
7.1.1 Europe Hepatic Encephalopathy Drugs Sales by Country (2017-2022)
7.1.2 Europe Hepatic Encephalopathy Drugs Revenue by Country (2017-2022)
7.2 Europe Hepatic Encephalopathy Drugs Sales by Type
7.3 Europe Hepatic Encephalopathy Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hepatic Encephalopathy Drugs by Country
8.1.1 Middle East & Africa Hepatic Encephalopathy Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Hepatic Encephalopathy Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Hepatic Encephalopathy Drugs Sales by Type
8.3 Middle East & Africa Hepatic Encephalopathy Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatic Encephalopathy Drugs
10.3 Manufacturing Process Analysis of Hepatic Encephalopathy Drugs
10.4 Industry Chain Structure of Hepatic Encephalopathy Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatic Encephalopathy Drugs Distributors
11.3 Hepatic Encephalopathy Drugs Customer
12 WORLD FORECAST REVIEW FOR HEPATIC ENCEPHALOPATHY DRUGS BY GEOGRAPHIC REGION
12.1 Global Hepatic Encephalopathy Drugs Market Size Forecast by Region
12.1.1 Global Hepatic Encephalopathy Drugs Forecast by Region (2023-2028)
12.1.2 Global Hepatic Encephalopathy Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hepatic Encephalopathy Drugs Forecast by Type
12.7 Global Hepatic Encephalopathy Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ASKA Pharmaceutical
13.1.1 ASKA Pharmaceutical Company Information
13.1.2 ASKA Pharmaceutical Hepatic Encephalopathy Drugs Product Offered
13.1.3 ASKA Pharmaceutical Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ASKA Pharmaceutical Main Business Overview
13.1.5 ASKA Pharmaceutical Latest Developments
13.2 Cosmo Pharmaceuticals
13.2.1 Cosmo Pharmaceuticals Company Information
13.2.2 Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Product Offered
13.2.3 Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Cosmo Pharmaceuticals Main Business Overview
13.2.5 Cosmo Pharmaceuticals Latest Developments
13.3 Bausch Health
13.3.1 Bausch Health Company Information
13.3.2 Bausch Health Hepatic Encephalopathy Drugs Product Offered
13.3.3 Bausch Health Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bausch Health Main Business Overview
13.3.5 Bausch Health Latest Developments
13.4 Ferring Pharmaceuticals
13.4.1 Ferring Pharmaceuticals Company Information
13.4.2 Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Product Offered
13.4.3 Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ferring Pharmaceuticals Main Business Overview
13.4.5 Ferring Pharmaceuticals Latest Developments
13.5 Mallinckrodt
13.5.1 Mallinckrodt Company Information
13.5.2 Mallinckrodt Hepatic Encephalopathy Drugs Product Offered
13.5.3 Mallinckrodt Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mallinckrodt Main Business Overview
13.5.5 Mallinckrodt Latest Developments
13.6 Umecrine Cognition
13.6.1 Umecrine Cognition Company Information
13.6.2 Umecrine Cognition Hepatic Encephalopathy Drugs Product Offered
13.6.3 Umecrine Cognition Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Umecrine Cognition Main Business Overview
13.6.5 Umecrine Cognition Latest Developments
13.7 Norgine
13.7.1 Norgine Company Information
13.7.2 Norgine Hepatic Encephalopathy Drugs Product Offered
13.7.3 Norgine Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Norgine Main Business Overview
13.7.5 Norgine Latest Developments
13.8 Lupin
13.8.1 Lupin Company Information
13.8.2 Lupin Hepatic Encephalopathy Drugs Product Offered
13.8.3 Lupin Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Lupin Main Business Overview
13.8.5 Lupin Latest Developments
13.9 Kaleido Biosciences
13.9.1 Kaleido Biosciences Company Information
13.9.2 Kaleido Biosciences Hepatic Encephalopathy Drugs Product Offered
13.9.3 Kaleido Biosciences Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Kaleido Biosciences Main Business Overview
13.9.5 Kaleido Biosciences Latest Developments
13.10 Kannalife Sciences
13.10.1 Kannalife Sciences Company Information
13.10.2 Kannalife Sciences Hepatic Encephalopathy Drugs Product Offered
13.10.3 Kannalife Sciences Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Kannalife Sciences Main Business Overview
13.10.5 Kannalife Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hepatic Encephalopathy Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Hepatic Encephalopathy Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Hepatic Encephalopathy Drugs by Country/Region, 2017, 2022 & 2028
2.2 Hepatic Encephalopathy Drugs Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 Hepatic Encephalopathy Drugs Sales by Type
2.3.1 Global Hepatic Encephalopathy Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Hepatic Encephalopathy Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Hepatic Encephalopathy Drugs Sale Price by Type (2017-2022)
2.4 Hepatic Encephalopathy Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Hepatic Encephalopathy Drugs Sales by Application
2.5.1 Global Hepatic Encephalopathy Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Hepatic Encephalopathy Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Hepatic Encephalopathy Drugs Sale Price by Application (2017-2022)
3 GLOBAL HEPATIC ENCEPHALOPATHY DRUGS BY COMPANY
3.1 Global Hepatic Encephalopathy Drugs Breakdown Data by Company
3.1.1 Global Hepatic Encephalopathy Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Hepatic Encephalopathy Drugs Sales Market Share by Company (2020-2022)
3.2 Global Hepatic Encephalopathy Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Hepatic Encephalopathy Drugs Revenue by Company (2020-2022)
3.2.2 Global Hepatic Encephalopathy Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Hepatic Encephalopathy Drugs Sale Price by Company
3.4 Key Manufacturers Hepatic Encephalopathy Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatic Encephalopathy Drugs Product Location Distribution
3.4.2 Players Hepatic Encephalopathy Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HEPATIC ENCEPHALOPATHY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Hepatic Encephalopathy Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Hepatic Encephalopathy Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Hepatic Encephalopathy Drugs Annual Revenue by Geographic Region
4.2 World Historic Hepatic Encephalopathy Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Hepatic Encephalopathy Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Hepatic Encephalopathy Drugs Annual Revenue by Country/Region
4.3 Americas Hepatic Encephalopathy Drugs Sales Growth
4.4 APAC Hepatic Encephalopathy Drugs Sales Growth
4.5 Europe Hepatic Encephalopathy Drugs Sales Growth
4.6 Middle East & Africa Hepatic Encephalopathy Drugs Sales Growth
5 AMERICAS
5.1 Americas Hepatic Encephalopathy Drugs Sales by Country
5.1.1 Americas Hepatic Encephalopathy Drugs Sales by Country (2017-2022)
5.1.2 Americas Hepatic Encephalopathy Drugs Revenue by Country (2017-2022)
5.2 Americas Hepatic Encephalopathy Drugs Sales by Type
5.3 Americas Hepatic Encephalopathy Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatic Encephalopathy Drugs Sales by Region
6.1.1 APAC Hepatic Encephalopathy Drugs Sales by Region (2017-2022)
6.1.2 APAC Hepatic Encephalopathy Drugs Revenue by Region (2017-2022)
6.2 APAC Hepatic Encephalopathy Drugs Sales by Type
6.3 APAC Hepatic Encephalopathy Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hepatic Encephalopathy Drugs by Country
7.1.1 Europe Hepatic Encephalopathy Drugs Sales by Country (2017-2022)
7.1.2 Europe Hepatic Encephalopathy Drugs Revenue by Country (2017-2022)
7.2 Europe Hepatic Encephalopathy Drugs Sales by Type
7.3 Europe Hepatic Encephalopathy Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hepatic Encephalopathy Drugs by Country
8.1.1 Middle East & Africa Hepatic Encephalopathy Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Hepatic Encephalopathy Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Hepatic Encephalopathy Drugs Sales by Type
8.3 Middle East & Africa Hepatic Encephalopathy Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatic Encephalopathy Drugs
10.3 Manufacturing Process Analysis of Hepatic Encephalopathy Drugs
10.4 Industry Chain Structure of Hepatic Encephalopathy Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatic Encephalopathy Drugs Distributors
11.3 Hepatic Encephalopathy Drugs Customer
12 WORLD FORECAST REVIEW FOR HEPATIC ENCEPHALOPATHY DRUGS BY GEOGRAPHIC REGION
12.1 Global Hepatic Encephalopathy Drugs Market Size Forecast by Region
12.1.1 Global Hepatic Encephalopathy Drugs Forecast by Region (2023-2028)
12.1.2 Global Hepatic Encephalopathy Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hepatic Encephalopathy Drugs Forecast by Type
12.7 Global Hepatic Encephalopathy Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ASKA Pharmaceutical
13.1.1 ASKA Pharmaceutical Company Information
13.1.2 ASKA Pharmaceutical Hepatic Encephalopathy Drugs Product Offered
13.1.3 ASKA Pharmaceutical Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ASKA Pharmaceutical Main Business Overview
13.1.5 ASKA Pharmaceutical Latest Developments
13.2 Cosmo Pharmaceuticals
13.2.1 Cosmo Pharmaceuticals Company Information
13.2.2 Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Product Offered
13.2.3 Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Cosmo Pharmaceuticals Main Business Overview
13.2.5 Cosmo Pharmaceuticals Latest Developments
13.3 Bausch Health
13.3.1 Bausch Health Company Information
13.3.2 Bausch Health Hepatic Encephalopathy Drugs Product Offered
13.3.3 Bausch Health Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bausch Health Main Business Overview
13.3.5 Bausch Health Latest Developments
13.4 Ferring Pharmaceuticals
13.4.1 Ferring Pharmaceuticals Company Information
13.4.2 Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Product Offered
13.4.3 Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ferring Pharmaceuticals Main Business Overview
13.4.5 Ferring Pharmaceuticals Latest Developments
13.5 Mallinckrodt
13.5.1 Mallinckrodt Company Information
13.5.2 Mallinckrodt Hepatic Encephalopathy Drugs Product Offered
13.5.3 Mallinckrodt Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mallinckrodt Main Business Overview
13.5.5 Mallinckrodt Latest Developments
13.6 Umecrine Cognition
13.6.1 Umecrine Cognition Company Information
13.6.2 Umecrine Cognition Hepatic Encephalopathy Drugs Product Offered
13.6.3 Umecrine Cognition Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Umecrine Cognition Main Business Overview
13.6.5 Umecrine Cognition Latest Developments
13.7 Norgine
13.7.1 Norgine Company Information
13.7.2 Norgine Hepatic Encephalopathy Drugs Product Offered
13.7.3 Norgine Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Norgine Main Business Overview
13.7.5 Norgine Latest Developments
13.8 Lupin
13.8.1 Lupin Company Information
13.8.2 Lupin Hepatic Encephalopathy Drugs Product Offered
13.8.3 Lupin Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Lupin Main Business Overview
13.8.5 Lupin Latest Developments
13.9 Kaleido Biosciences
13.9.1 Kaleido Biosciences Company Information
13.9.2 Kaleido Biosciences Hepatic Encephalopathy Drugs Product Offered
13.9.3 Kaleido Biosciences Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Kaleido Biosciences Main Business Overview
13.9.5 Kaleido Biosciences Latest Developments
13.10 Kannalife Sciences
13.10.1 Kannalife Sciences Company Information
13.10.2 Kannalife Sciences Hepatic Encephalopathy Drugs Product Offered
13.10.3 Kannalife Sciences Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Kannalife Sciences Main Business Overview
13.10.5 Kannalife Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hepatic Encephalopathy Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Hepatic Encephalopathy Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Global Hepatic Encephalopathy Drugs Sales by Type (2017-2022) & (MT)
Table 6. Global Hepatic Encephalopathy Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Hepatic Encephalopathy Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Hepatic Encephalopathy Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Hepatic Encephalopathy Drugs Sale Price by Type (2017-2022) & (USD/Kg)
Table 10. Global Hepatic Encephalopathy Drugs Sales by Application (2017-2022) & (MT)
Table 11. Global Hepatic Encephalopathy Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Hepatic Encephalopathy Drugs Revenue by Application (2017-2022)
Table 13. Global Hepatic Encephalopathy Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Hepatic Encephalopathy Drugs Sale Price by Application (2017-2022) & (USD/Kg)
Table 15. Global Hepatic Encephalopathy Drugs Sales by Company (2020-2022) & (MT)
Table 16. Global Hepatic Encephalopathy Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Hepatic Encephalopathy Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Hepatic Encephalopathy Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Hepatic Encephalopathy Drugs Sale Price by Company (2020-2022) & (USD/Kg)
Table 20. Key Manufacturers Hepatic Encephalopathy Drugs Producing Area Distribution and Sales Area
Table 21. Players Hepatic Encephalopathy Drugs Products Offered
Table 22. Hepatic Encephalopathy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hepatic Encephalopathy Drugs Sales by Geographic Region (2017-2022) & (MT)
Table 26. Global Hepatic Encephalopathy Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Hepatic Encephalopathy Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Hepatic Encephalopathy Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Hepatic Encephalopathy Drugs Sales by Country/Region (2017-2022) & (MT)
Table 30. Global Hepatic Encephalopathy Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Hepatic Encephalopathy Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Hepatic Encephalopathy Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Hepatic Encephalopathy Drugs Sales by Country (2017-2022) & (MT)
Table 34. Americas Hepatic Encephalopathy Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Hepatic Encephalopathy Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Hepatic Encephalopathy Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Hepatic Encephalopathy Drugs Sales by Type (2017-2022) & (MT)
Table 38. Americas Hepatic Encephalopathy Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Hepatic Encephalopathy Drugs Sales by Application (2017-2022) & (MT)
Table 40. Americas Hepatic Encephalopathy Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Hepatic Encephalopathy Drugs Sales by Region (2017-2022) & (MT)
Table 42. APAC Hepatic Encephalopathy Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Hepatic Encephalopathy Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Hepatic Encephalopathy Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Hepatic Encephalopathy Drugs Sales by Type (2017-2022) & (MT)
Table 46. APAC Hepatic Encephalopathy Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Hepatic Encephalopathy Drugs Sales by Application (2017-2022) & (MT)
Table 48. APAC Hepatic Encephalopathy Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Hepatic Encephalopathy Drugs Sales by Country (2017-2022) & (MT)
Table 50. Europe Hepatic Encephalopathy Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Hepatic Encephalopathy Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Hepatic Encephalopathy Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Hepatic Encephalopathy Drugs Sales by Type (2017-2022) & (MT)
Table 54. Europe Hepatic Encephalopathy Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Hepatic Encephalopathy Drugs Sales by Application (2017-2022) & (MT)
Table 56. Europe Hepatic Encephalopathy Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Hepatic Encephalopathy Drugs Sales by Country (2017-2022) & (MT)
Table 58. Middle East & Africa Hepatic Encephalopathy Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Hepatic Encephalopathy Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Hepatic Encephalopathy Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Hepatic Encephalopathy Drugs Sales by Type (2017-2022) & (MT)
Table 62. Middle East & Africa Hepatic Encephalopathy Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Hepatic Encephalopathy Drugs Sales by Application (2017-2022) & (MT)
Table 64. Middle East & Africa Hepatic Encephalopathy Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Hepatic Encephalopathy Drugs
Table 66. Key Market Challenges & Risks of Hepatic Encephalopathy Drugs
Table 67. Key Industry Trends of Hepatic Encephalopathy Drugs
Table 68. Hepatic Encephalopathy Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Hepatic Encephalopathy Drugs Distributors List
Table 71. Hepatic Encephalopathy Drugs Customer List
Table 72. Global Hepatic Encephalopathy Drugs Sales Forecast by Region (2023-2028) & (MT)
Table 73. Global Hepatic Encephalopathy Drugs Sales Market Forecast by Region
Table 74. Global Hepatic Encephalopathy Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Hepatic Encephalopathy Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Hepatic Encephalopathy Drugs Sales Forecast by Country (2023-2028) & (MT)
Table 77. Americas Hepatic Encephalopathy Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Hepatic Encephalopathy Drugs Sales Forecast by Region (2023-2028) & (MT)
Table 79. APAC Hepatic Encephalopathy Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Hepatic Encephalopathy Drugs Sales Forecast by Country (2023-2028) & (MT)
Table 81. Europe Hepatic Encephalopathy Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Hepatic Encephalopathy Drugs Sales Forecast by Country (2023-2028) & (MT)
Table 83. Middle East & Africa Hepatic Encephalopathy Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Hepatic Encephalopathy Drugs Sales Forecast by Type (2023-2028) & (MT)
Table 85. Global Hepatic Encephalopathy Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Hepatic Encephalopathy Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Hepatic Encephalopathy Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Hepatic Encephalopathy Drugs Sales Forecast by Application (2023-2028) & (MT)
Table 89. Global Hepatic Encephalopathy Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Hepatic Encephalopathy Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Hepatic Encephalopathy Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. ASKA Pharmaceutical Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. ASKA Pharmaceutical Hepatic Encephalopathy Drugs Product Offered
Table 94. ASKA Pharmaceutical Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 95. ASKA Pharmaceutical Main Business
Table 96. ASKA Pharmaceutical Latest Developments
Table 97. Cosmo Pharmaceuticals Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Product Offered
Table 99. Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 100. Cosmo Pharmaceuticals Main Business
Table 101. Cosmo Pharmaceuticals Latest Developments
Table 102. Bausch Health Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Bausch Health Hepatic Encephalopathy Drugs Product Offered
Table 104. Bausch Health Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 105. Bausch Health Main Business
Table 106. Bausch Health Latest Developments
Table 107. Ferring Pharmaceuticals Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Product Offered
Table 109. Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 110. Ferring Pharmaceuticals Main Business
Table 111. Ferring Pharmaceuticals Latest Developments
Table 112. Mallinckrodt Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Mallinckrodt Hepatic Encephalopathy Drugs Product Offered
Table 114. Mallinckrodt Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 115. Mallinckrodt Main Business
Table 116. Mallinckrodt Latest Developments
Table 117. Umecrine Cognition Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Umecrine Cognition Hepatic Encephalopathy Drugs Product Offered
Table 119. Umecrine Cognition Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 120. Umecrine Cognition Main Business
Table 121. Umecrine Cognition Latest Developments
Table 122. Norgine Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Norgine Hepatic Encephalopathy Drugs Product Offered
Table 124. Norgine Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 125. Norgine Main Business
Table 126. Norgine Latest Developments
Table 127. Lupin Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Lupin Hepatic Encephalopathy Drugs Product Offered
Table 129. Lupin Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 130. Lupin Main Business
Table 131. Lupin Latest Developments
Table 132. Kaleido Biosciences Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Kaleido Biosciences Hepatic Encephalopathy Drugs Product Offered
Table 134. Kaleido Biosciences Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 135. Kaleido Biosciences Main Business
Table 136. Kaleido Biosciences Latest Developments
Table 137. Kannalife Sciences Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Kannalife Sciences Hepatic Encephalopathy Drugs Product Offered
Table 139. Kannalife Sciences Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 140. Kannalife Sciences Main Business
Table 141. Kannalife Sciences Latest Developments
Table 1. Hepatic Encephalopathy Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Hepatic Encephalopathy Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Global Hepatic Encephalopathy Drugs Sales by Type (2017-2022) & (MT)
Table 6. Global Hepatic Encephalopathy Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Hepatic Encephalopathy Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Hepatic Encephalopathy Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Hepatic Encephalopathy Drugs Sale Price by Type (2017-2022) & (USD/Kg)
Table 10. Global Hepatic Encephalopathy Drugs Sales by Application (2017-2022) & (MT)
Table 11. Global Hepatic Encephalopathy Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Hepatic Encephalopathy Drugs Revenue by Application (2017-2022)
Table 13. Global Hepatic Encephalopathy Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Hepatic Encephalopathy Drugs Sale Price by Application (2017-2022) & (USD/Kg)
Table 15. Global Hepatic Encephalopathy Drugs Sales by Company (2020-2022) & (MT)
Table 16. Global Hepatic Encephalopathy Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Hepatic Encephalopathy Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Hepatic Encephalopathy Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Hepatic Encephalopathy Drugs Sale Price by Company (2020-2022) & (USD/Kg)
Table 20. Key Manufacturers Hepatic Encephalopathy Drugs Producing Area Distribution and Sales Area
Table 21. Players Hepatic Encephalopathy Drugs Products Offered
Table 22. Hepatic Encephalopathy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hepatic Encephalopathy Drugs Sales by Geographic Region (2017-2022) & (MT)
Table 26. Global Hepatic Encephalopathy Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Hepatic Encephalopathy Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Hepatic Encephalopathy Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Hepatic Encephalopathy Drugs Sales by Country/Region (2017-2022) & (MT)
Table 30. Global Hepatic Encephalopathy Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Hepatic Encephalopathy Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Hepatic Encephalopathy Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Hepatic Encephalopathy Drugs Sales by Country (2017-2022) & (MT)
Table 34. Americas Hepatic Encephalopathy Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Hepatic Encephalopathy Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Hepatic Encephalopathy Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Hepatic Encephalopathy Drugs Sales by Type (2017-2022) & (MT)
Table 38. Americas Hepatic Encephalopathy Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Hepatic Encephalopathy Drugs Sales by Application (2017-2022) & (MT)
Table 40. Americas Hepatic Encephalopathy Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Hepatic Encephalopathy Drugs Sales by Region (2017-2022) & (MT)
Table 42. APAC Hepatic Encephalopathy Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Hepatic Encephalopathy Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Hepatic Encephalopathy Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Hepatic Encephalopathy Drugs Sales by Type (2017-2022) & (MT)
Table 46. APAC Hepatic Encephalopathy Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Hepatic Encephalopathy Drugs Sales by Application (2017-2022) & (MT)
Table 48. APAC Hepatic Encephalopathy Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Hepatic Encephalopathy Drugs Sales by Country (2017-2022) & (MT)
Table 50. Europe Hepatic Encephalopathy Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Hepatic Encephalopathy Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Hepatic Encephalopathy Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Hepatic Encephalopathy Drugs Sales by Type (2017-2022) & (MT)
Table 54. Europe Hepatic Encephalopathy Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Hepatic Encephalopathy Drugs Sales by Application (2017-2022) & (MT)
Table 56. Europe Hepatic Encephalopathy Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Hepatic Encephalopathy Drugs Sales by Country (2017-2022) & (MT)
Table 58. Middle East & Africa Hepatic Encephalopathy Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Hepatic Encephalopathy Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Hepatic Encephalopathy Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Hepatic Encephalopathy Drugs Sales by Type (2017-2022) & (MT)
Table 62. Middle East & Africa Hepatic Encephalopathy Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Hepatic Encephalopathy Drugs Sales by Application (2017-2022) & (MT)
Table 64. Middle East & Africa Hepatic Encephalopathy Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Hepatic Encephalopathy Drugs
Table 66. Key Market Challenges & Risks of Hepatic Encephalopathy Drugs
Table 67. Key Industry Trends of Hepatic Encephalopathy Drugs
Table 68. Hepatic Encephalopathy Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Hepatic Encephalopathy Drugs Distributors List
Table 71. Hepatic Encephalopathy Drugs Customer List
Table 72. Global Hepatic Encephalopathy Drugs Sales Forecast by Region (2023-2028) & (MT)
Table 73. Global Hepatic Encephalopathy Drugs Sales Market Forecast by Region
Table 74. Global Hepatic Encephalopathy Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Hepatic Encephalopathy Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Hepatic Encephalopathy Drugs Sales Forecast by Country (2023-2028) & (MT)
Table 77. Americas Hepatic Encephalopathy Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Hepatic Encephalopathy Drugs Sales Forecast by Region (2023-2028) & (MT)
Table 79. APAC Hepatic Encephalopathy Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Hepatic Encephalopathy Drugs Sales Forecast by Country (2023-2028) & (MT)
Table 81. Europe Hepatic Encephalopathy Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Hepatic Encephalopathy Drugs Sales Forecast by Country (2023-2028) & (MT)
Table 83. Middle East & Africa Hepatic Encephalopathy Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Hepatic Encephalopathy Drugs Sales Forecast by Type (2023-2028) & (MT)
Table 85. Global Hepatic Encephalopathy Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Hepatic Encephalopathy Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Hepatic Encephalopathy Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Hepatic Encephalopathy Drugs Sales Forecast by Application (2023-2028) & (MT)
Table 89. Global Hepatic Encephalopathy Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Hepatic Encephalopathy Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Hepatic Encephalopathy Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. ASKA Pharmaceutical Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. ASKA Pharmaceutical Hepatic Encephalopathy Drugs Product Offered
Table 94. ASKA Pharmaceutical Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 95. ASKA Pharmaceutical Main Business
Table 96. ASKA Pharmaceutical Latest Developments
Table 97. Cosmo Pharmaceuticals Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Product Offered
Table 99. Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 100. Cosmo Pharmaceuticals Main Business
Table 101. Cosmo Pharmaceuticals Latest Developments
Table 102. Bausch Health Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Bausch Health Hepatic Encephalopathy Drugs Product Offered
Table 104. Bausch Health Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 105. Bausch Health Main Business
Table 106. Bausch Health Latest Developments
Table 107. Ferring Pharmaceuticals Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Product Offered
Table 109. Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 110. Ferring Pharmaceuticals Main Business
Table 111. Ferring Pharmaceuticals Latest Developments
Table 112. Mallinckrodt Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Mallinckrodt Hepatic Encephalopathy Drugs Product Offered
Table 114. Mallinckrodt Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 115. Mallinckrodt Main Business
Table 116. Mallinckrodt Latest Developments
Table 117. Umecrine Cognition Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Umecrine Cognition Hepatic Encephalopathy Drugs Product Offered
Table 119. Umecrine Cognition Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 120. Umecrine Cognition Main Business
Table 121. Umecrine Cognition Latest Developments
Table 122. Norgine Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Norgine Hepatic Encephalopathy Drugs Product Offered
Table 124. Norgine Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 125. Norgine Main Business
Table 126. Norgine Latest Developments
Table 127. Lupin Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Lupin Hepatic Encephalopathy Drugs Product Offered
Table 129. Lupin Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 130. Lupin Main Business
Table 131. Lupin Latest Developments
Table 132. Kaleido Biosciences Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Kaleido Biosciences Hepatic Encephalopathy Drugs Product Offered
Table 134. Kaleido Biosciences Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 135. Kaleido Biosciences Main Business
Table 136. Kaleido Biosciences Latest Developments
Table 137. Kannalife Sciences Basic Information, Hepatic Encephalopathy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Kannalife Sciences Hepatic Encephalopathy Drugs Product Offered
Table 139. Kannalife Sciences Hepatic Encephalopathy Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 140. Kannalife Sciences Main Business
Table 141. Kannalife Sciences Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hepatic Encephalopathy Drugs
Figure 2. Hepatic Encephalopathy Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hepatic Encephalopathy Drugs Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Hepatic Encephalopathy Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Hepatic Encephalopathy Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Oral
Figure 11. Global Hepatic Encephalopathy Drugs Sales Market Share by Type in 2021
Figure 12. Global Hepatic Encephalopathy Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Hepatic Encephalopathy Drugs Consumed in Hospital Pharmacies
Figure 14. Global Hepatic Encephalopathy Drugs Market: Hospital Pharmacies (2017-2022) & (MT)
Figure 15. Hepatic Encephalopathy Drugs Consumed in Retail Pharmacies
Figure 16. Global Hepatic Encephalopathy Drugs Market: Retail Pharmacies (2017-2022) & (MT)
Figure 17. Hepatic Encephalopathy Drugs Consumed in Online Pharmacies
Figure 18. Global Hepatic Encephalopathy Drugs Market: Online Pharmacies (2017-2022) & (MT)
Figure 19. Global Hepatic Encephalopathy Drugs Sales Market Share by Application (2017-2022)
Figure 20. Global Hepatic Encephalopathy Drugs Revenue Market Share by Application in 2021
Figure 21. Hepatic Encephalopathy Drugs Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Hepatic Encephalopathy Drugs Revenue Market Share by Company in 2021
Figure 23. Global Hepatic Encephalopathy Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Hepatic Encephalopathy Drugs Revenue Market Share by Geographic Region in 2021
Figure 25. Global Hepatic Encephalopathy Drugs Sales Market Share by Region (2017-2022)
Figure 26. Global Hepatic Encephalopathy Drugs Revenue Market Share by Country/Region in 2021
Figure 27. Americas Hepatic Encephalopathy Drugs Sales 2017-2022 (MT)
Figure 28. Americas Hepatic Encephalopathy Drugs Revenue 2017-2022 ($ Millions)
Figure 29. APAC Hepatic Encephalopathy Drugs Sales 2017-2022 (MT)
Figure 30. APAC Hepatic Encephalopathy Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Europe Hepatic Encephalopathy Drugs Sales 2017-2022 (MT)
Figure 32. Europe Hepatic Encephalopathy Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Hepatic Encephalopathy Drugs Sales 2017-2022 (MT)
Figure 34. Middle East & Africa Hepatic Encephalopathy Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Americas Hepatic Encephalopathy Drugs Sales Market Share by Country in 2021
Figure 36. Americas Hepatic Encephalopathy Drugs Revenue Market Share by Country in 2021
Figure 37. United States Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Hepatic Encephalopathy Drugs Sales Market Share by Region in 2021
Figure 42. APAC Hepatic Encephalopathy Drugs Revenue Market Share by Regions in 2021
Figure 43. China Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Hepatic Encephalopathy Drugs Sales Market Share by Country in 2021
Figure 50. Europe Hepatic Encephalopathy Drugs Revenue Market Share by Country in 2021
Figure 51. Germany Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Hepatic Encephalopathy Drugs Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Hepatic Encephalopathy Drugs Revenue Market Share by Country in 2021
Figure 58. Egypt Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Hepatic Encephalopathy Drugs in 2021
Figure 64. Manufacturing Process Analysis of Hepatic Encephalopathy Drugs
Figure 65. Industry Chain Structure of Hepatic Encephalopathy Drugs
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Hepatic Encephalopathy Drugs
Figure 2. Hepatic Encephalopathy Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hepatic Encephalopathy Drugs Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Hepatic Encephalopathy Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Hepatic Encephalopathy Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Oral
Figure 11. Global Hepatic Encephalopathy Drugs Sales Market Share by Type in 2021
Figure 12. Global Hepatic Encephalopathy Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Hepatic Encephalopathy Drugs Consumed in Hospital Pharmacies
Figure 14. Global Hepatic Encephalopathy Drugs Market: Hospital Pharmacies (2017-2022) & (MT)
Figure 15. Hepatic Encephalopathy Drugs Consumed in Retail Pharmacies
Figure 16. Global Hepatic Encephalopathy Drugs Market: Retail Pharmacies (2017-2022) & (MT)
Figure 17. Hepatic Encephalopathy Drugs Consumed in Online Pharmacies
Figure 18. Global Hepatic Encephalopathy Drugs Market: Online Pharmacies (2017-2022) & (MT)
Figure 19. Global Hepatic Encephalopathy Drugs Sales Market Share by Application (2017-2022)
Figure 20. Global Hepatic Encephalopathy Drugs Revenue Market Share by Application in 2021
Figure 21. Hepatic Encephalopathy Drugs Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Hepatic Encephalopathy Drugs Revenue Market Share by Company in 2021
Figure 23. Global Hepatic Encephalopathy Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Hepatic Encephalopathy Drugs Revenue Market Share by Geographic Region in 2021
Figure 25. Global Hepatic Encephalopathy Drugs Sales Market Share by Region (2017-2022)
Figure 26. Global Hepatic Encephalopathy Drugs Revenue Market Share by Country/Region in 2021
Figure 27. Americas Hepatic Encephalopathy Drugs Sales 2017-2022 (MT)
Figure 28. Americas Hepatic Encephalopathy Drugs Revenue 2017-2022 ($ Millions)
Figure 29. APAC Hepatic Encephalopathy Drugs Sales 2017-2022 (MT)
Figure 30. APAC Hepatic Encephalopathy Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Europe Hepatic Encephalopathy Drugs Sales 2017-2022 (MT)
Figure 32. Europe Hepatic Encephalopathy Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Hepatic Encephalopathy Drugs Sales 2017-2022 (MT)
Figure 34. Middle East & Africa Hepatic Encephalopathy Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Americas Hepatic Encephalopathy Drugs Sales Market Share by Country in 2021
Figure 36. Americas Hepatic Encephalopathy Drugs Revenue Market Share by Country in 2021
Figure 37. United States Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Hepatic Encephalopathy Drugs Sales Market Share by Region in 2021
Figure 42. APAC Hepatic Encephalopathy Drugs Revenue Market Share by Regions in 2021
Figure 43. China Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Hepatic Encephalopathy Drugs Sales Market Share by Country in 2021
Figure 50. Europe Hepatic Encephalopathy Drugs Revenue Market Share by Country in 2021
Figure 51. Germany Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Hepatic Encephalopathy Drugs Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Hepatic Encephalopathy Drugs Revenue Market Share by Country in 2021
Figure 58. Egypt Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Hepatic Encephalopathy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Hepatic Encephalopathy Drugs in 2021
Figure 64. Manufacturing Process Analysis of Hepatic Encephalopathy Drugs
Figure 65. Industry Chain Structure of Hepatic Encephalopathy Drugs
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
